<DOC>
	<DOCNO>NCT02563665</DOCNO>
	<brief_summary>All patient chronic kidney disease ( stag 3 , 4 5 ) chronic dialysis patient HCV infection attend nephrology Hepatology OPD get outpatient dialysis dialysis unit ILBS .</brief_summary>
	<brief_title>Safety Efficacy Sofosbuvir Based Antiviral Regimen Treating Hepatitis C Patients With Moderate Advanced Chronic Kidney Disease Patients Receiving Renal Replacement Therapy</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>1 . Patients moderate severe renal dysfunction ( CKD stage 3 , 4 , 5 ) chronic dialysis patient 2 . Patients consent study protocol signing informed consent . 1 . Age le 18 year 2 . Confirmed pregnancy 3 . HCVHIV Co infection 4 . HBVHCV co infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>